Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer-Reference-Cited by-同舟云学术

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

Published:2008-12 Issue:6 Volume:3 Page:761-776
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Saad Maha¹,Garbuzenko Olga B¹,Minko Tamara¹

Affiliation:

1. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854-08020, USA.

Abstract

Aims: To develop a novel nanomedicine approach for the treatment of multidrug-resistant (MDR) cancer by combining an anticancer drug and suppressors of cellular resistance within one multifunctional nanocarrier-based delivery system (NDS). Materials & methods: The NDS consisted of cationic liposomes (carrier, 100–140 nm), doxorubicin (DOX, anticancer drug), siRNA targeted to MRP1 and BCL2 mRNA (suppressors of pump and nonpump cellular-resistance, respectively). The resulting approximately 500 nm complex has a zeta potential of +4 mV. Results & discussion: The NDS provides an effective co-delivery of DOX and siRNA as well as cell-death induction and suppression of cellular resistance in MDR lung cancer cells. Conclusion: We demonstrate NDS-enhanced efficiency of chemotherapy to a level that cannot be achieved by applying its components separately.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/17435889.3.6.761

Reference62 articles.

1. Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular Defense

2. MinkoT, Khandare JJ, Vetcher AAet al.: Multifunctional nanotherapeutics for cancer (Chapter 10). In:Multifunctional Pharmaceutical Nanocarriers. Series: Fundamental Biomedical Technologies.Torchilin VP (Ed.). Springer, New York, NY, USA (2008).

3. Relationship Between Chemotherapy Response of Small Cell Lung Cancer and P-glycoprotein or Multidrug Resistance-Related Protein Expression

4. Multidrug resistance in non-small-cell lung cancer

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential application of nanotechnology in the treatment and overcoming of pancreatic cancer resistance;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

2. Vesicular drug delivery systems: a novel approach in current nanomedicine;Molecular Pharmaceutics and Nano Drug Delivery;2024

3. Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance;Nanomedicine;2023-11-15

4. Recent advances in codelivery of curcumin and siRNA as anticancer therapeutics;European Polymer Journal;2023-10

5. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10